Whalen Biomedical Incorporated (WBI) is involved with R&D in the areas of medical devices and materials, with an emphasis on devices for cardiovascular, orthopedic, and urologic applications. It is also developing timed drug release systems for a variety of medical applications. With an emphasis on devices for cardiovascular, dental, orthopedic, and urologic applications, and drug delivery systems. In addition to the firm's SBIR support, the company conducts sponsored research for commercial customers, offers custom device fabrication services, and provides engineering consulting services to other organizations. WBI has a portfolio of 7 U.S. patents protecting its proprietary technology. While the company is not currently involved in manufacturing, it has a wholly owned subsidiary, Cambridge Cardiovascular Incorporated, which is chartered as a manufacturing company in Massachusetts.
